MRPL12 and lung adenocarcinoma: As shown in Figure 9C, upregulation of MRPL22 (HR = 1.5, p = 0.0048), MRPL28 (HR = 1.5, p = 0.0098), MRPL21 (HR = 1.7, p = 0.001), MRPL12 (HR = 1.7, p = 0.00059), MRPS12 (HR = 1.6, p = 0.002), and MRPL17 (HR = 1.5, p = 0.0051) were correlated with poor overall survival in lung adenocarcinoma.